Clinical Trials Logo

Lichen Planus, Oral clinical trials

View clinical trials related to Lichen Planus, Oral.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06060301 Active, not recruiting - Oral Lichen Planus Clinical Trials

Topical Sulfasalazine and Oral Lichen Planus

Start date: March 1, 2023
Phase: Phase 3
Study type: Interventional

Oral lichen planus (OLP) is a chronic inflammatory disease that affects the mucosal membrane. T-cell mediated damage against the mucosal epithelial cells is implicated in the pathogenesis of OLP, although the exact mechanism is unknown. Sulfasalazine is extensively used in inflammatory bowel disease and is effective on immune-related inflammatory disease such as Crohn's disease, rheumatoid arthritis, and Behcet's disease. In spite of its effectiveness, the anti-inflammatory mechanism is not clearly understood.

NCT ID: NCT04336488 Active, not recruiting - Oral Lichen Planus Clinical Trials

Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus

Start date: January 1, 2020
Phase: Early Phase 1
Study type: Interventional

The current study will be conducted to evaluate the effectiveness of matrix metalloproteinases inhibitors on erosive oral lichen planus.